Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D7GS
|
|||
| Former ID |
DNCL001734
|
|||
| Drug Name |
MultiStem
|
|||
| Synonyms |
MultiStem (TN)
Click to Show/Hide
|
|||
| Indication | Ischemic stroke [ICD-11: 8B11.5Z; ICD-9: 434.91] | Phase 3 | [1] | |
| Acute myocardial infarction [ICD-11: BA41; ICD-9: 410] | Phase 2 | [2] | ||
| AIDS-related lymphoma [ICD-11: 2B33.5; ICD-10: C85.9] | Phase 2 | [3] | ||
| Graft-versus-host disease [ICD-11: 4B24] | Phase 2 | [3] | ||
| Spinal cord injury [ICD-11: ND51.2] | Phase 2 | [3] | ||
| Company |
Athersys
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03545607) MultiStem Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | ClinicalTrials.gov (NCT02277613) A Phase 2 Trial of AMI MultiStem Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.